Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

North America Transcriptomics Market

North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity
Report code: SDMRHE1652021 | Industry: Healthcare and Social Assistance | Published On: 10/31/2022
 Sample & Brochure   Talk to Analyst   Request Customization  Make an enquiry   Discount

North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 32 tables and 43 figures, this 114-page report “North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.

Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
• Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 7
1.1  Industry  Definition  and  Research  Scope 7
1.1.1  Industry  Definition 7
1.1.2  Research  Scope 9
1.2  Research  Methodology 12
1.2.1  Overview  of  Market  Research  Methodology 12
1.2.2  Market  Assumption 13
1.2.3  Secondary  Data 13
1.2.4  Primary  Data 13
1.2.5  Data  Filtration  and  Model  Design 14
1.2.6  Market  Size/Share  Estimation 15
1.2.7  Research  Limitations 16
1.3  Executive  Summary 17
2  Market  Overview  and  Dynamics 20
2.1  Market  Size  and  Forecast 20
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 23
2.2  Major  Growth  Drivers 25
2.3  Market  Restraints  and  Challenges 30
2.4  Emerging  Opportunities  and  Market  Trends 33
2.5  Porter’s  Fiver  Forces  Analysis 37
3  Segmentation  of  North  America  Market  by  Component 41
3.1  Market  Overview  by  Component 41
3.2  Instruments 43
3.3  Consumables 45
3.4  Software 47
3.5  Services 49
4  Segmentation  of  North  America  Market  by  Technology 50
4.1  Market  Overview  by  Technology 50
4.2  Polymerase  Chain  Reaction  (PCR) 52
4.3  Next-Generation  Sequencing 54
4.4  Microarray 56
4.5  In-Situ  Hybridization  (ISH) 58
4.6  Gene  Regulation  Technologies 60
4.7  Other  Technologies 61
5  Segmentation  of  North  America  Market  by  Application 62
5.1  Market  Overview  by  Application 62
5.2  Drug  Discovery  and  Development 64
5.3  Diagnostics 65
5.4  Single  Cell  Analysis 66
5.5  Gene  Expression 67
5.6  Cell  Biology 68
5.7  Other  Applications 69
6  Segmentation  of  North  America  Market  by  End  User 70
6.1  Market  Overview  by  End  User 70
6.2  Academic  and  Research  Institutions 72
6.3  Biotechnology  and  Biopharmaceutical  Companies 73
6.4  Contract  Research  Organizations  (CROs) 74
6.5  Other  End  Users 75
7  North  America  Market  2021-2031  by  Country 76
7.1  Overview  of  North  America  Market 76
7.2  U.S. 79
7.3  Canada 82
7.4  Mexico 84
8  Competitive  Landscape 86
8.1  Overview  of  Key  Vendors 86
8.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 91
8.3  Company  Profiles 92
10x  Genomics 92
Agilent  Technologies,  Inc. 94
ANGLE  plc 95
Becton,  Dickinson  and  Company  (BD) 96
Bio-Rad  Laboratories,  Inc. 97
BioSypder,  Inc. 98
Bio-Techne 99
Cytiva 100
F.  Hoffmann-La  Roche  Ltd. 101
Fluidigm  Corporation 102
GE  Healthcare 103
Illumina,  Inc. 104
Menarini  Silicon  Biosystems 105
Merck  &  Co.,  Inc. 106
NanoString 107
Pacific  Biosciences  of  California,  Inc. 108
PerkinElmer  Inc. 109
Promega  Corporation 110
Qiagen  N.  V. 111
Takara  Bio  Inc. 112
Thermo  Fisher  Scientific  Inc. 113
RELATED  REPORTS 114
List of Tables:

Table 1. Snapshot of North America Transcriptomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Transcriptome Databases 28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn 29
Table 5. Main Product Trends and Market Opportunities in North America Transcriptomics Market 33
Table 6. North America Transcriptomics Market by Component, 2021-2031, $ mn 41
Table 7. Main Instrument Products from Key Vendors 44
Table 8. Main Consumable Products from Key Vendors 46
Table 9. Main Software Products from Key Vendors 48
Table 10. North America Transcriptomics Market by Technology, 2021-2031, $ mn 50
Table 11. Main PCR-based Transcriptomics and Key Vendors 53
Table 12. Main NGS-based Transcriptomics and Key Vendors 55
Table 13. Main Microarray-based Transcriptomics and Key Vendors 57
Table 14. Main ISH-based Transcriptomics and Key Vendors 59
Table 15. North America Transcriptomics Market by Application, 2021-2031, $ mn 62
Table 16. North America Transcriptomics Market by End User, 2021-2031, $ mn 70
Table 17. North America Transcriptomics Market by Country, 2021-2031, $ mn 77
Table 18. U.S. Transcriptomics Market by Component, 2021-2031, $ mn 81
Table 19. U.S. Transcriptomics Market by Technology, 2021-2031, $ mn 81
Table 20. U.S. Transcriptomics Market by Application, 2021-2031, $ mn 81
Table 21. Canada Transcriptomics Market by Component, 2021-2031, $ mn 83
Table 22. Canada Transcriptomics Market by Technology, 2021-2031, $ mn 83
Table 23. Canada Transcriptomics Market by Application, 2021-2031, $ mn 83
Table 24. Mexico Transcriptomics Market by Component, 2021-2031, $ mn 85
Table 25. Mexico Transcriptomics Market by Technology, 2021-2031, $ mn 85
Table 26. Mexico Transcriptomics Market by Application, 2021-2031, $ mn 85
Table 27. Transcriptomic Products Approved by FDA 88
Table 28. Sequencing Technology Platforms for RNA-Sequencing 89
Table 29. RNA-Sequencing De Novo Assembly Software 89
Table 30. 10x Genomics: Company Snapshot 92
Table 31. 10x Genomics: Business Segmentation 93
Table 32. 10x Genomics: Product Portfolio 93
 Feel free to contact us

 
Choose License Type
Select User Type


Report code


Buy Now

x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT